SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/51D35A57F670C043012C7CD0910198AA6A874BD30CF3D762C59551B11617DFE1AD9C3E0972754D5C89E927B0F0F3D815>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/51D35A57F670C043012C7CD0910198AA6A874BD30CF3D762C59551B11617DFE1AD9C3E0972754D5C89E927B0F0F3D815
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/51D35A57F670C043012C7CD0910198AA6A874BD30CF3D762C59551B11617DFE1AD9C3E0972754D5C89E927B0F0F3D815
http://www.w3.org/2000/01/rdf-schema#comment
"Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients."
xsd:string
http://purl.uniprot.org/uniprot/#_0907F6F3ADFB5BD1955CDB2ACA83F005342362DB7E205B9BB9A32F8D7D753A6FBEE5AE79E3C7E59AC5CF00412233BD05
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/51D35A57F670C043012C7CD0910198AA6A874BD30CF3D762C59551B11617DFE1AD9C3E0972754D5C89E927B0F0F3D815
http://purl.uniprot.org/uniprot/C3RUE0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/51D35A57F670C043012C7CD0910198AA6A874BD30CF3D762C59551B11617DFE1AD9C3E0972754D5C89E927B0F0F3D815
http://purl.uniprot.org/uniprot/#_C3RUE0-mappedCitation-31853860
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/51D35A57F670C043012C7CD0910198AA6A874BD30CF3D762C59551B11617DFE1AD9C3E0972754D5C89E927B0F0F3D815